Literature DB >> 18853127

[Simvastatin-induced dermatomyositis].

A Rasch1, M Schimmer, C A Sander.   

Abstract

Dermatomyositis is a rare inflammatory autoimmune disease. The association between a lipid-lowering drug like pravastatin and the development of a musculocutaneous syndrome has been reported in single case reports only. We present the first report of a simvastatin induced dermatomyositis in a 71-year-old woman with positive Mi-2-Antibodies to point out this rare side effect of the increasingly prescribed statins. In future simvastatin should be considered as a possible trigger of dermatomyositis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18853127     DOI: 10.1007/s00105-008-1637-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  11 in total

1.  [Pravastatin-induced dermatomyositis].

Authors:  P Zuech; C Pauwels; C Duthoit; L Méry; A Somogyi; A Louboutin; C Veyssier-Belot
Journal:  Rev Med Interne       Date:  2005-08-25       Impact factor: 0.728

Review 2.  Fluvastatin.

Authors:  J M Lawrence; J P D Reckless
Journal:  Expert Opin Pharmacother       Date:  2002-11       Impact factor: 3.889

Review 3.  Drug-induced myopathies. An overview of the possible mechanisms.

Authors:  Jacek Owczarek; Magdalena Jasińska; Daria Orszulak-Michalak
Journal:  Pharmacol Rep       Date:  2005 Jan-Feb       Impact factor: 3.024

4.  [Fluvastatin-induced dermatomyositis].

Authors:  N Thual; K Penven; J-M Chevallier; A Dompmartin; D Leroy
Journal:  Ann Dermatol Venereol       Date:  2005-12       Impact factor: 0.777

Review 5.  Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.

Authors:  E H S Choy; J E Hoogendijk; B Lecky; J B Winer
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

6.  Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake.

Authors:  Olavo M Vasconcelos; William W Campbell
Journal:  Muscle Nerve       Date:  2004-12       Impact factor: 3.217

7.  Lupus-like syndrome associated with statin therapy.

Authors:  Bernard Noël; Renato G Panizzon
Journal:  Dermatology       Date:  2004       Impact factor: 5.366

8.  [Polymyositis induced or associated with lipid-lowering drugs: five cases].

Authors:  A-L Fauchais; J Iba Ba; P Maurage; X Kyndt; D Bataille; E Hachulla; D Parent; V Queyrel; M Lambert; U Michon Pasturel; P-Y Hatron; P Vanhille; B Devulder
Journal:  Rev Med Interne       Date:  2004-04       Impact factor: 0.728

Review 9.  Iatrogenic and toxic myopathies.

Authors:  Joern P Sieb; Thomas Gillessen
Journal:  Muscle Nerve       Date:  2003-02       Impact factor: 3.217

10.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

Authors:  M C Dalakas; I Illa; J M Dambrosia; S A Soueidan; D P Stein; C Otero; S T Dinsmore; S McCrosky
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  2 in total

1.  Simvastatin-induced dermatomyositis in a 50-year-old man.

Authors:  Inés Rania Zaraa; Imen Labbène; Dalila Mrabet; Hela Zribi; Inès Chelly; Mohamed Zitouna; Mourad Mokni; Slaheddine Sellami; Amel Ben Osman
Journal:  BMJ Case Rep       Date:  2011-03-29

Review 2.  Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review.

Authors:  Isabela Bruna Pires Borges; Marilda Guimarães Silva; Rafael Giovane Misse; Samuel Katsuyuki Shinjo
Journal:  Rheumatol Int       Date:  2017-10-12       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.